Navigation Links
Chiltern Expands North American Operations With a New Office in Illinois
Date:9/29/2011

LONDON, Sept. 29, 2011 /PRNewswire/ -- Chiltern International (Chiltern), a global clinical contract research organization (CRO) announced that it has opened a new office in the Chicago area, specifically in Bannockburn, IL.

Mr. Barry Simms, Chiltern's Country Manager, North America, commented, "Chiltern continues to look for opportunities to increase our strategic footprint and we are very excited about our expansion to the greater Chicago area. Our new office is well situated to support our efforts to recruit top-notch staff and be strategically near our clients."

"We are extremely pleased by the success we have had attracting high-qualified staff to our Bannockburn office, and we welcome our new colleagues to the team," Dr. Jim Esinhart, Sr. Executive VP, Global Scientific Services, Chiltern, stated. "Our new office supports Chiltern's mission to deliver high quality services around the world, while demonstrating our commitment to clients' needs."

Company profile About Chiltern: Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs nearly 1,300 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at www.chiltern.com. For More Information Contact: Natalie Chong, Marketing Director

Susan Ojanen, Marketing Executive Chiltern International Ltd.

Chiltern International Inc. 171 Bath Road

1241 Volunteer Parkway Slough

Suite 950 Berkshire SL1 4AA

Bristol, TN 37620 UNITED KINGDOM

USATel: +44 (0) 1753 512 000

Tel: +1 (423) 968 9533 Fax: +44 (0) 1753 511 116

Fax: +1 (423) 968 3567 Email: natalie.chong@chiltern.com

Email: susan.ojanen@chiltern.com
'/>"/>

SOURCE Chiltern
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chiltern Wins Multiple Pharma Awards at the Prestigious Annual PharmaTimes Awards Ceremony
2. Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years
3. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
4. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
5. Cellectar Expands Clinical Management Team
6. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
7. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
8. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
9. PAREXEL Expands Global Clinical Pharmacology Capabilities
10. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
11. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... DUBLIN , Mar 29, 2017 Research ... Global Market - Forecast to 2023" report to their offering. ... The ablation ... CAGR to reach $20,995.5 million by 2023. Ablation ... wide range of purposes, from cancerous or diseased tissue removal, to ...
(Date:3/29/2017)...  Spiral Therapeutics, Inc. today announced the signature ... for the worldwide exclusive rights to Bionure,s lead ... of otolaryngology for aggregate payments of up to ... provides Spiral with the option to license two ... Under the terms of the agreement, Spiral will ...
(Date:3/29/2017)... 2017   Royal Philips (NYSE: PHG, ... and PathAI, a company that develops artificial intelligence ... to develop solutions that improve the precision and ... diseases. The partnership aims to build deep learning ... artificial intelligence to be applied to massive pathology ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... Patients interested in receiving ... from Dr. Jamie Cameron, with or without a referral. The FASTBRACES system is ... Depending on each patient’s case, treatment with the FASTBRACES system could be completed ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... (GRMA) is growing as it continues developing an ANSI-approved, consensus-based American National ... organization, which plans to publish the first ANSI-approved GMP standard for dietary ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... for documenting and diagramming network and data center assets and audio-video devices has ... can request new equipment shapes for free and download shapes and stencils from ...
(Date:3/29/2017)... ... March 29, 2017 , ... An ... braces. "The rubber bands used in conjunction with my braces always rubbed against ... design a way to prevent this problem." The O.B.S. was the result of ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... many scientific laboratories. The assembly protocols involve many repetitive steps and often scientists ... automation, which enables the high-throughput needed, and results in a lower error rate ...
Breaking Medicine News(10 mins):